Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea

@inproceedings{Moon2013LevofloxacinMA,
  title={Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea},
  author={Ji Yoon Moon and Gwang Ha Kim and Hyun Seok You and Bong Eun Lee and Dong Yeop Ryu and Jae Hoon Cheong and Jung Im Jung and Jae Hoon Jeong and Chul Soo Song and Geun Am Song},
  booktitle={Gut and liver},
  year={2013}
}
BACKGROUND/AIMS Several rescue therapies have been recommended to eradicate Helicobacter pylori infection in patients with a failure of first-line eradication therapy, but they still fail in more than 20% of cases. The aim of this study was to evaluate the efficacy and safety of levofloxacin, metronidazole, and lansoprazole (LML) triple therapy relative to quadruple therapy as a second-line treatment. METHODS In total, 113 patients who failed first-line triple therapy for H. pylori infection… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Similar Papers

Loading similar papers…